GlassScriptPhysician profile
Jelena C Eddy
NPI 1386020659
$1,648.40
in general payments reported to CMS, 2019-2025
14 companies · $726 in 2025
The $726 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $118 · 2022: $110 · 2023: $188 · 2024: $506 · 2025: $726.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $945 · Education: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $944.51 |
| Education | $475.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $373.04 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $318.52 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $184.44 | 2024-2025 | Dupixent |
| Biohaven Pharmaceuticals, INC. | $118.41 | 2021 | |
| Sanofi-Aventis U.S. LLC | $96.99 | 2025 | |
| Journey Medical Corporation | $96.00 | 2025 | |
| Genzyme Corporation | $95.79 | 2025 | |
| Incyte Corporation | $94.99 | 2023 | |
| Janssen Scientific Affairs, LLC | $93.28 | 2023 | Xarelto |
| Galderma Laboratories, L.P. | $50.93 | 2025 | Nemluvio |
| Organon LLC | $50.31 | 2025 | |
| Leo Pharma INC. | $30.64 | 2025 | Anzupgo |
| Biofrontera INC. | $23.44 | 2025 | Ameluz |
| Janssen Biotech, INC. | $21.62 | 2025 | Tremfya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jelena Eddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.